Tumor regression of multiple bone metastases from breast cancer after administration of strontium-89 chloride (Metastron).
Article Details
- CitationCopy to clipboard
Heianna J, Miyauchi T, Endo W, Miura N, Terui K, Kamata S, Hashimoto M
Tumor regression of multiple bone metastases from breast cancer after administration of strontium-89 chloride (Metastron).
Acta Radiol Short Rep. 2014 May 10;3(4):2047981613493412. doi: 10.1177/2047981613493412. eCollection 2014 May.
- PubMed ID
- 25298863 [ View in PubMed]
- Abstract
We report a case of tumor regression of multiple bone metastases from breast carcinoma after administration of strontium-89 chloride. This case suggests that strontium-89 chloride can not only relieve bone metastases pain not responsive to analgesics, but may also have a tumoricidal effect on bone metastases.
DrugBank Data that Cites this Article
- Drugs